|
NL6815872A
(enExample)
|
1967-11-22 |
1969-05-27 |
|
|
|
JPS5614663B2
(enExample)
|
1971-08-21 |
1981-04-06 |
|
|
|
US4582833A
(en)
|
1984-04-16 |
1986-04-15 |
American Cyanamid Company |
2-(substituted-1-piperazinyl)[1,2,4]triazolo[1,5-a]pyrimidines
|
|
US4576943A
(en)
|
1984-10-09 |
1986-03-18 |
American Cyanamid Company |
Pyrazolo[1,5-a]pyrimidines
|
|
US5308852A
(en)
|
1992-06-29 |
1994-05-03 |
Merck Frosst Canada, Inc. |
Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis
|
|
US6506876B1
(en)
|
1994-10-11 |
2003-01-14 |
G.D. Searle & Co. |
LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use
|
|
AU1952597A
(en)
|
1996-02-13 |
1997-09-02 |
G.D. Searle & Co. |
Combinations, having immunosuppressive effects, containing cyclooxygenase-2 inhibitor and a leukotriene a4 hydrolase inhibitor
|
|
US5952349A
(en)
|
1996-07-10 |
1999-09-14 |
Schering Corporation |
Muscarinic antagonists for treating memory loss
|
|
US6309561B1
(en)
|
1997-12-24 |
2001-10-30 |
3M Innovative Properties Company |
Liquid crystal compounds having a chiral fluorinated terminal portion
|
|
US6380203B1
(en)
*
|
1998-01-14 |
2002-04-30 |
Merck & Co., Inc. |
Angiogenesis inhibitors
|
|
GB9815880D0
(en)
|
1998-07-21 |
1998-09-16 |
Pfizer Ltd |
Heterocycles
|
|
GB9919776D0
(en)
|
1998-08-31 |
1999-10-27 |
Zeneca Ltd |
Compoujnds
|
|
AR023659A1
(es)
|
1998-09-18 |
2002-09-04 |
Vertex Pharma |
Un compuesto inhibidor de p38, una composicion farmaceutica que lo comprende y el uso de dicha composicion en el tratamiento y prevencion de estados patologicos
|
|
US6699873B1
(en)
|
1999-08-04 |
2004-03-02 |
Millennium Pharmaceuticals, Inc. |
Melanocortin-4 receptor binding compounds and methods of use thereof
|
|
US6924313B1
(en)
|
1999-09-23 |
2005-08-02 |
Pfizer Inc. |
Substituted tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
|
|
AU2001234420A1
(en)
|
2000-02-03 |
2001-08-14 |
Eli Lilly And Company |
Potentiators of glutamate receptors
|
|
US6451798B2
(en)
|
2000-02-22 |
2002-09-17 |
Cv Therapeutics, Inc. |
Substituted alkyl piperazine derivatives
|
|
US6552023B2
(en)
|
2000-02-22 |
2003-04-22 |
Cv Therapeutics, Inc. |
Aralkyl substituted piperazine compounds
|
|
JP2001354657A
(ja)
|
2000-06-09 |
2001-12-25 |
Sds Biotech:Kk |
置換ピペラジン誘導体及び農園芸用殺菌剤
|
|
US6875483B2
(en)
|
2000-07-06 |
2005-04-05 |
Fuji Photo Film Co., Ltd. |
Liquid crystal composition comprising liquid crystal molecules and alignment promoter
|
|
WO2002064211A1
(en)
|
2001-02-09 |
2002-08-22 |
Merck & Co., Inc. |
Thrombin inhibitors
|
|
DE60229114D1
(en)
|
2001-03-02 |
2008-11-13 |
Axys Pharm Inc |
Cathepsincystein-proteasehemmer
|
|
AUPR362001A0
(en)
|
2001-03-08 |
2001-04-05 |
Fujisawa Pharmaceutical Co., Ltd. |
New compound
|
|
FR2826011B1
(fr)
|
2001-06-14 |
2004-12-10 |
Oreal |
Nouveaux derives de la 7-oxo-dhea et utilisation cosmetique
|
|
SE0102616D0
(sv)
|
2001-07-25 |
2001-07-25 |
Astrazeneca Ab |
Novel compounds
|
|
IL160845A0
(en)
|
2001-09-14 |
2004-08-31 |
Tularik Inc |
Linked biaryl compounds
|
|
AU2002363236A1
(en)
|
2001-10-30 |
2003-05-12 |
Millennium Pharmaceuticals, Inc. |
Compounds, pharmaceutical compositions and methods of use therefor
|
|
US7851486B2
(en)
|
2002-10-17 |
2010-12-14 |
Decode Genetics Ehf. |
Susceptibility gene for myocardial infarction, stroke, and PAOD; methods of treatment
|
|
AU2003290527A1
(en)
|
2002-10-17 |
2004-05-04 |
Decode Genetics Ehf. |
Susceptibility gene for myocardial infarction
|
|
US20040198777A1
(en)
|
2002-12-20 |
2004-10-07 |
Mitokor, Inc. |
Ligands of adenine nucleotide translocase (ANT) and compositions and methods related thereto
|
|
JPWO2004089410A1
(ja)
|
2003-04-03 |
2006-07-06 |
協和醗酵工業株式会社 |
神経因性疼痛の予防及び／または治療剤
|
|
WO2004099164A1
(en)
|
2003-05-02 |
2004-11-18 |
Rigel Pharmaceuticals, Inc. |
Substituted diphenyl isoxazoles, pyrazoles and oxadiazoles useful for treating hcv infection
|
|
JP2005008581A
(ja)
*
|
2003-06-20 |
2005-01-13 |
Kissei Pharmaceut Co Ltd |
新規なピラゾロ［１，５−ａ］ピリミジン誘導体、それを含有する医薬組成物およびそれらの用途
|
|
WO2005012296A1
(en)
|
2003-07-28 |
2005-02-10 |
Janssen Pharmaceutica N.V. |
Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators
|
|
CA2539276A1
(en)
|
2003-09-17 |
2005-03-31 |
Decode Genetics Ehf. |
Methods of preventing or treating recurrence of myocardial infarction
|
|
DE10356579A1
(de)
*
|
2003-12-04 |
2005-07-07 |
Merck Patent Gmbh |
Aminderivate
|
|
SE0303480D0
(sv)
|
2003-12-19 |
2003-12-19 |
Biovitrum Ab |
Benzofuranes
|
|
ATE437880T1
(de)
|
2004-02-04 |
2009-08-15 |
Neurosearch As |
Dimere azacyclische verbindungen und deren verwendung
|
|
WO2006033795A2
(en)
*
|
2004-09-17 |
2006-03-30 |
Wyeth |
Substituted pyrazolo [1, 5-a] pyrimidines for inhibiting abnormal cell growth
|
|
WO2006105304A2
(en)
|
2005-03-31 |
2006-10-05 |
Janssen Pharmaceutica N.V. |
Phenyl and pyridyl lta4h modulators
|
|
GB0514018D0
(en)
|
2005-07-07 |
2005-08-17 |
Ionix Pharmaceuticals Ltd |
Chemical compounds
|
|
BRPI0616187A2
(pt)
|
2005-09-21 |
2011-06-14 |
Decode Genetics Ehf |
composto, composiÇço farmacÊutica, e, uso de uma quantidade terapeuticamente eficaz de um composto
|
|
CN1947717B
(zh)
|
2005-10-14 |
2012-09-26 |
卓敏 |
选择性抑制腺苷酸环化酶1的化合物在制备用于治疗神经性疼痛和炎性疼痛的药物中的应用
|
|
DE102005049954A1
(de)
|
2005-10-19 |
2007-05-31 |
Sanofi-Aventis Deutschland Gmbh |
Triazolopyridin-derivate als Inhibitoren von Lipasen und Phospholipasen
|
|
EP3205644A1
(en)
|
2005-12-29 |
2017-08-16 |
Celtaxsys Inc. |
Diamine derivatives as inhibitors of leukotriene a4 hydrolase
|
|
CN102633783A
(zh)
|
2006-02-10 |
2012-08-15 |
转化技术制药公司 |
作为Aurora激酶抑制剂的苯并唑系衍生物、组合物和使用方法
|
|
EP2058309A4
(en)
*
|
2006-08-04 |
2010-12-22 |
Takeda Pharmaceutical |
CONDENSED HETEROCYCLIC COMPOUND
|
|
BRPI0718059A2
(pt)
|
2006-10-19 |
2013-11-05 |
Holffmann La Roche Ag F |
Aminometil-2-imidazóis com afinidade com os receptores amina-associado traço
|
|
ES2620818T3
(es)
|
2006-12-14 |
2017-06-29 |
Janssen Pharmaceutica N.V. |
Procedimiento para la preparación de derivados de piperazinil y diazepanil benzamida
|
|
FR2911138B1
(fr)
|
2007-01-05 |
2009-02-20 |
Sanofi Aventis Sa |
Nouveaux derives de n, n'-2,4-dianilinopyrimidines, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
|
FR2911140B1
(fr)
|
2007-01-05 |
2009-02-20 |
Sanofi Aventis Sa |
Nouveaux derives de 2-anilino 4-heteroaryle pyrimides, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
|
FR2911139A1
(fr)
|
2007-01-05 |
2008-07-11 |
Sanofi Aventis Sa |
Nouveaux derives de phenyl-(4-phenyl-pyrimidin-2-yl)amines, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
|
|
RU2010103104A
(ru)
|
2007-07-02 |
2011-08-10 |
Ф.Хоффманн-Ля Рош Аг (Ch) |
Производные имидазола в качестве антагонистов рецептора ccr2
|
|
US7902181B2
(en)
|
2007-12-12 |
2011-03-08 |
Astrazeneca Ab |
Compounds 010
|
|
EA201001359A1
(ru)
*
|
2008-02-26 |
2011-04-29 |
Новартис Аг |
Гетероциклические соединения в качестве ингибиторов cxcr2
|
|
US20100029657A1
(en)
|
2008-02-29 |
2010-02-04 |
Wyeth |
Bridged, Bicyclic Heterocyclic or Spiro Bicyclic Heterocyclic Derivatives of Pyrazolo[1, 5-A]Pyrimidines, Methods for Preparation and Uses Thereof
|
|
EP2110374A1
(en)
|
2008-04-18 |
2009-10-21 |
Merck Sante |
Benzofurane, benzothiophene, benzothiazol derivatives as FXR modulators
|
|
WO2010011912A1
(en)
|
2008-07-25 |
2010-01-28 |
Smithkline Beecham Corporation |
Trpv4 antagonists
|
|
CN102030700B
(zh)
|
2009-09-30 |
2016-06-01 |
中国医学科学院药物研究所 |
苯甲酰胺基羧酸类化合物及其制法和药物用途
|
|
EP2493852B1
(en)
|
2009-10-30 |
2014-04-09 |
Janssen Pharmaceutica NV |
4-substituted-2-phenoxy-phenylamine delta opioid receptor modulators
|
|
AU2010328419A1
(en)
|
2009-12-07 |
2012-06-21 |
Targacept, Inc. |
3,6-diazabicyclo[3.1.1]heptanes as neuronal nicotinic acetylcholine receptor ligands
|
|
HUE052110T2
(hu)
|
2010-07-29 |
2021-04-28 |
Rigel Pharmaceuticals Inc |
AMPK-t aktiváló heterociklusos vegyületek és alkalmazásuk
|
|
US8609669B2
(en)
*
|
2010-11-16 |
2013-12-17 |
Abbvie Inc. |
Potassium channel modulators
|
|
WO2012125832A2
(en)
|
2011-03-15 |
2012-09-20 |
Rib-X Pharmaceuticals, Inc. |
Antimicrobial agents
|
|
EP2714661B1
(en)
|
2011-05-23 |
2015-09-30 |
Janssen Pharmaceutica, N.V. |
Picolinamido - propanoic acid derivatives useful as glucagon receptor antagonists
|
|
CN103159742B
(zh)
|
2011-12-16 |
2015-08-12 |
北京韩美药品有限公司 |
5-氯嘧啶类化合物及其作为egfr酪氨酸激酶抑制剂的应用
|
|
US9006235B2
(en)
*
|
2012-03-06 |
2015-04-14 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
|
AU2014249168B2
(en)
|
2013-03-12 |
2018-07-12 |
Celltaxis, Llc |
Methods of inhibiting leukotriene A4 hydrolase
|
|
AU2014240042C1
(en)
|
2013-03-14 |
2019-09-05 |
Celltaxis, Llc |
Inhibitors of leukotriene A4 hydrolase
|
|
EP2968265A4
(en)
|
2013-03-14 |
2016-12-28 |
Celtaxsys Inc |
INHIBITORS OF THE LEUKOTRIEN A4 HYDROLASE
|